IL144228A0 - Use of apoptosis inducing agents in the treatment of (auto) immune diseases - Google Patents

Use of apoptosis inducing agents in the treatment of (auto) immune diseases

Info

Publication number
IL144228A0
IL144228A0 IL14422800A IL14422800A IL144228A0 IL 144228 A0 IL144228 A0 IL 144228A0 IL 14422800 A IL14422800 A IL 14422800A IL 14422800 A IL14422800 A IL 14422800A IL 144228 A0 IL144228 A0 IL 144228A0
Authority
IL
Israel
Prior art keywords
auto
immune diseases
treatment
inducing agents
apoptosis inducing
Prior art date
Application number
IL14422800A
Other languages
English (en)
Original Assignee
Leadd Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leadd Bv filed Critical Leadd Bv
Publication of IL144228A0 publication Critical patent/IL144228A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL14422800A 1999-01-11 2000-01-10 Use of apoptosis inducing agents in the treatment of (auto) immune diseases IL144228A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99200056 1999-01-11
PCT/NL2000/000013 WO2000041497A2 (en) 1999-01-11 2000-01-10 Use of apoptosis inducing agents in the treatment of (auto)immune diseases

Publications (1)

Publication Number Publication Date
IL144228A0 true IL144228A0 (en) 2002-05-23

Family

ID=8239795

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14422800A IL144228A0 (en) 1999-01-11 2000-01-10 Use of apoptosis inducing agents in the treatment of (auto) immune diseases
IL144228A IL144228A (en) 1999-01-11 2001-07-10 Use of apoptosis inducing agents in the preparation of a medicament for the treatment of (auto) immune diseases

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL144228A IL144228A (en) 1999-01-11 2001-07-10 Use of apoptosis inducing agents in the preparation of a medicament for the treatment of (auto) immune diseases

Country Status (18)

Country Link
US (1) US20050271624A1 (ru)
EP (1) EP1143994B1 (ru)
JP (1) JP2003500336A (ru)
AT (1) ATE244014T1 (ru)
AU (1) AU3083500A (ru)
CA (1) CA2359392A1 (ru)
DE (1) DE60003632T2 (ru)
DK (1) DK1143994T3 (ru)
EA (1) EA200100770A1 (ru)
ES (1) ES2202039T3 (ru)
HU (1) HUP0200552A2 (ru)
IL (2) IL144228A0 (ru)
MX (1) MXPA01006998A (ru)
NO (1) NO20013397L (ru)
PT (1) PT1143994E (ru)
TR (1) TR200102713T2 (ru)
WO (1) WO2000041497A2 (ru)
ZA (1) ZA200105632B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002246455A1 (en) * 2001-03-30 2002-10-15 Leadd B.V. Fusion proteins for specific treatment of cancer and auto-immune diseases
CA2448348C (en) * 2001-05-25 2013-07-16 Nymox Corporation Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
KR101005130B1 (ko) * 2001-07-19 2011-01-04 니목스 코포레이션 종양 및 세포의 제거 또는 파괴를 필요로 하는 다른질환의 치료에 효과적인 펩티드
US7317077B2 (en) 2001-11-16 2008-01-08 Nymox Pharmaceutical Corporation Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5670488A (en) * 1992-12-03 1997-09-23 Genzyme Corporation Adenovirus vector for gene therapy
US5981502A (en) * 1990-09-12 1999-11-09 Leadd B.V. Methods and compositions for inducing apoptosis in tumor cells
EP0878546A1 (en) * 1997-04-15 1998-11-18 Leadd B.V. A gene delivery vehicle expressing the apoptosis-inducing proteins VP2 and/or apoptin
US5792751A (en) * 1992-04-13 1998-08-11 Baylor College Of Medicine Tranformation of cells associated with fluid spaces
PT830604E (pt) * 1995-06-07 2003-10-31 Leadd Bv Utilizacoes da apoptina
WO1997029201A2 (de) * 1996-02-07 1997-08-14 Max-Delbrück-Centrum für Molekulare Medizin Retroviraler vektor für den gentransfer eines il6-antagonisten in humane hämatopoetische stammzellen
BR9807622A (pt) * 1997-02-28 2000-02-15 Boehringer Ingelheim Pharma Apoptose auto-regulada de células inflamatórias por terapia de gene
JPH10324699A (ja) * 1997-03-21 1998-12-08 Sankyo Co Ltd 抗ヒトＦａｓヒト化抗体
IL123756A0 (en) * 1997-03-21 1998-10-30 Sankyo Co Humanized anti-human FAS antibody

Also Published As

Publication number Publication date
DE60003632D1 (de) 2003-08-07
DE60003632T2 (de) 2004-04-15
NO20013397L (no) 2001-09-11
EP1143994B1 (en) 2003-07-02
IL144228A (en) 2009-06-15
WO2000041497A3 (en) 2000-09-28
MXPA01006998A (es) 2002-05-06
TR200102713T2 (tr) 2002-05-21
JP2003500336A (ja) 2003-01-07
NO20013397D0 (no) 2001-07-09
EP1143994A2 (en) 2001-10-17
ES2202039T3 (es) 2004-04-01
AU3083500A (en) 2000-08-01
CA2359392A1 (en) 2000-07-20
EA200100770A1 (ru) 2002-02-28
HUP0200552A2 (en) 2002-06-29
WO2000041497A2 (en) 2000-07-20
PT1143994E (pt) 2003-11-28
ATE244014T1 (de) 2003-07-15
US20050271624A1 (en) 2005-12-08
ZA200105632B (en) 2002-10-09
DK1143994T3 (da) 2003-10-20

Similar Documents

Publication Publication Date Title
MX2008001865A (es) Proteinas de fusion de albumina.
PT1157042E (pt) Produção de anticorpos tetravalentes
MXPA02012743A (es) Moleculas tipo il-17 y usos de las mismas.
MXPA03002413A (es) Moleculas tipo b7 y uso de las mismas.
WO2003048327A3 (en) Anti-cd45rb antibodies for use in treating autoimmune disease and transplant rejection
MX2009002816A (es) Proteinas de fusion de albumina.
EP1005540A4 (en) IKK-BETA PROTEINS, NUCLEIC ACIDS AND METHODS
WO2001064889A3 (en) Tnf-alpha variants for the treatment of tnf-alpha related disorders
AU8881201A (en) Tnf receptor-like molecules and uses thereof
WO2002018620A3 (en) Neutrokine-alpha and neutrokine-alpha splice variant
WO2003033658A3 (en) Neutrokine-alpha and neutrokine-alpha splice variant
WO2001098491A3 (en) Osteolevin gene polymorphisms
WO1999028461A3 (en) Methods and means for inducing apoptosis by interfering with bip-like proteins
IL144228A0 (en) Use of apoptosis inducing agents in the treatment of (auto) immune diseases
IL154298A0 (en) Papap proteins, their preparation and use
MXPA03000979A (es) Moleculas tipo receptor de complemento c3b/c4b y usos de las mismas.
MXPA03010728A (es) Moleculas de proteina-2 relacionadas con b7 y uso de las mismas.
PL374550A1 (en) Il-17 like molecules and uses thereof
EP1161262A4 (en) COLLIGIN / HsP47 WITH SURFACE LOCATION IN CARCINOMA CELLS
WO2004020591A3 (en) Methods of use for novel human polypeptides encoded by polynucleotides
EP1475441A3 (fr) Acides nucléiques et polypeptides spécifiques des souches pathogènes du genre Neisseria
WO2002072632A3 (en) Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof.
WO2001072826A3 (en) Oncogenic osteomalacia-related gene 1
WO2002079222A3 (en) Fusion proteins for specific treatment of cancer and auto-immune diseases
WO2002044366A3 (en) Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379